동물용 통증 관리 시장 : 제품 유형, 동물 유형, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Veterinary Pain Management Market was valued at USD 1.89 billion in 2023, expected to reach USD 2.07 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 3.63 billion by 2030.

The veterinary pain management market focuses on alleviating pain in animals through pharmaceutical, therapeutic, and alternative treatments. This sector is driven by the necessity to enhance animal welfare, improve recovery and quality of life, and meet the increasing pet ownership and livestock care demand. Its application spans across various animal segments, including companion animals like dogs and cats, and livestock such as cattle and horses, addressing diverse conditions from post-surgical pain to chronic ailments like arthritis. The end-use scope includes veterinary hospitals, clinics, rehabilitation centers, and research institutions, highlighting its extensive integration into animal healthcare.

Market growth is significantly influenced by factors such as rising awareness about animal health, advancements in veterinary healthcare infrastructure, and increasing initiatives for animal rights. Moreover, new technologies, such as pain management apps and telemedicine for real-time monitoring, present potential opportunities. Companies can capitalize on these by investing in R&D for innovative drug development, and personalized treatment approaches, or enhancing digital health tools. Strategic collaborations between veterinary pharmaceutical companies and animal health organizations could foster growth and expand market reach.

However, certain challenges may impede market expansion, including stringent regulatory policies, high costs of treatment, and a lack of awareness in developing regions. Overcoming these hurdles will require industry players to focus on cost-effective, scalable solutions and educational campaigns to boost acceptance and implementation in underrepresented areas.

Innovations in pain management techniques, such as utilizing genomics for tailored therapies or developing multifunctional pain relief formulations, represent promising growth areas. Furthermore, attention toward sustainable and organic compounds for pain relief could redefine industry standards, catering to environmentally conscious consumers. The veterinary pain management market is inherently dynamic, with opportunities skewed toward technological integration and accessibility improvements, making these areas ripe for investment and exploration for businesses aiming for long-term growth and market leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Pain Management Market

The Veterinary Pain Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Improving veterinary care facilities in economies
  • Rising incidence of chronic diseases and accidental injuries in animals
• Market Restraints
  • High cost of veterinary treatments and therapeutics
• Market Opportunities
  • Improving pet insurance services worldwide
  • Research and developments in veterinary pain management
• Market Challenges
  • Limited availability of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Pain Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Pain Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Pain Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Pain Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Pain Management Market

A detailed market share analysis in the Veterinary Pain Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Pain Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Pain Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Pain Management Market

A strategic analysis of the Veterinary Pain Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Pain Management Market, highlighting leading vendors and their innovative profiles. These include Ashish Life Science Pvt. Ltd., B. Braun Melsungen AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Endovac Animal Health, LLC, K-Laser USA Inc., Merck KGaA, Norbrook Laboratories Limited, Ourofino Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Device and Drugs. The Device is further studied across Electromagnetic Device and Laser Therapy Device. The Drugs is further studied across Alpha-2 Agonists, Disease-Modifying Osteoarthritis Agents, Local Anesthetics, NSAIDS, and Opioids.
• Based on Animal Type, market is studied across Companion Animal and Livestock Animal.
• Based on Application, market is studied across Cancer Pain, Joint Pain, and Postoperative Pain. The Joint Pain is further studied across Musculoskeletal and Osteoarthritis.
• Based on End User, market is studied across Pharmacies & Drug Store, Veterinary Clinics, and Veterinary Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Improving veterinary care facilities in economies
    • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary treatments and therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Improving pet insurance services worldwide
    • 5.1.3.2. Research and developments in veterinary pain management
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Pain Management Market, by Product

• 6.1. Introduction
• 6.2. Device
  • 6.2.1. Electromagnetic Device
  • 6.2.2. Laser Therapy Device
• 6.3. Drugs
  • 6.3.1. Alpha-2 Agonists
  • 6.3.2. Disease-Modifying Osteoarthritis Agents
  • 6.3.3. Local Anesthetics
  • 6.3.4. NSAIDS
  • 6.3.5. Opioids

7. Veterinary Pain Management Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animal
• 7.3. Livestock Animal

8. Veterinary Pain Management Market, by Application

• 8.1. Introduction
• 8.2. Cancer Pain
• 8.3. Joint Pain
  • 8.3.1. Musculoskeletal
  • 8.3.2. Osteoarthritis
• 8.4. Postoperative Pain

9. Veterinary Pain Management Market, by End User

• 9.1. Introduction
• 9.2. Pharmacies & Drug Store
• 9.3. Veterinary Clinics
• 9.4. Veterinary Hospitals

10. Americas Veterinary Pain Management Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Pain Management Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Pain Management Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ashish Life Science Pvt. Ltd.
• 2. B. Braun Melsungen AG
• 3. Boehringer Ingelheim International GmbH
• 4. Ceva Sante Animale
• 5. Chanelle Pharma
• 6. Dechra Pharmaceuticals PLC
• 7. Elanco Animal Health Incorporated
• 8. Endovac Animal Health, LLC
• 9. K-Laser USA Inc.
• 10. Merck KGaA
• 11. Norbrook Laboratories Limited
• 12. Ourofino Group
• 13. Vetoquinol S.A.
• 14. Virbac S.A.
• 15. Zoetis Inc.